{"id":69005,"date":"2026-03-13T11:51:26","date_gmt":"2026-03-13T11:51:26","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69005"},"modified":"2026-05-21T07:14:11","modified_gmt":"2026-05-21T07:14:11","slug":"cjc-1295-without-dac","status":"publish","type":"product","link":"https:\/\/medsbase.com\/sv\/product\/cjc-1295-without-dac\/","title":{"rendered":"CJC-1295 utan DAC"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Quick Answer \u2014 What is CJC-1295 without DAC?<\/h3>\n<p style=\"margin: 0;\"><strong>CJC-1295 utan DAC<\/strong> (also called <strong>Mod GRF 1-29<\/strong>) is a synthetic modified GHRH (1-29) analog with a short ~30-minute plasma half-life. Unlike the DAC version, it lacks the albumin-binding tether, producing a <strong>pulsatile<\/strong> rather than sustained GH signal. This kinetic profile makes it the preferred research tool when pulse-timing matters. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials for laboratory research use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Vad du f\u00e5r med MedsBase:<\/strong> Forskningsgrad av liofiliserade peptider \u00b7 HPLC \u226599% renhet (COA p\u00e5 beg\u00e4ran) \u00b7 Diskret temperaturstabil f\u00f6rpackning \u00b7 Peptidbud \u00f6ver hela v\u00e4rlden \u00b7 1 400+ verifierade <a href=\"https:\/\/medsbase.com\/sv\/reviews\/\">kundrecensioner<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r <a href=\"https:\/\/medsbase.com\/sv\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalj<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">863288-34-0 (parent) \u00b7 446262-90-4 (Mod-GRF 1\u201329 form widely cited)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekylformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>152<\/sub>H<sub>252<\/sub>N<sub>44<\/sub>O<sub>42<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekylvikt<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">3367.92 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sekvens<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Ala-Tyr-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH<sub>2<\/sub> (Mod-GRF 1\u201329, no DAC linker)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliserat pulver (eller som levereras)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Renhet<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (HPLC-verifierat, COA p\u00e5 beg\u00e4ran)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f6rvaring<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyofiliserat: 2\u20138 \u00b0C (kylsk\u00e5p) f\u00f6r arbetslager; \u221220 \u00b0C f\u00f6r l\u00e5ngtidslagring av o\u00f6ppnade flaskor. Rekonstituerat: 2\u20138 \u00b0C, anv\u00e4nd inom ~30 dagar. Skydda fr\u00e5n ljus. Frys inte upp och tina den rekonstituerade l\u00f6sningen.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slighet<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatisk vatten (rekommenderas) eller sterilt vatten f\u00f6r kortare anv\u00e4ndningsperioder<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forskningsanv\u00e4ndning<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Endast f\u00f6r laboratorieforskning. Ej avsedd f\u00f6r diagnostiskt eller terapeutiskt bruk p\u00e5 m\u00e4nniskor eller djur.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>What Is CJC-1295 without DAC?<\/h2>\n<p><strong>CJC-1295 utan DAC<\/strong> (commonly called <strong>Mod GRF 1-29<\/strong> or simply <strong>tetrasubstituted GRF 1-29<\/strong>) is a synthetic 30-amino-acid analog of growth-hormone-releasing hormone. It shares the same core peptide sequence as <a href=\"https:\/\/medsbase.com\/sv\/cjc-1295-with-dac\/\">CJC-1295 med DAC<\/a> \u2014 four amino-acid substitutions on the native GHRH (1-29) sequence provide resistance to DPP-IV cleavage \u2014 but <strong>lacks the albumin-binding DAC modification<\/strong> that extends half-life in the &#8220;with DAC&#8221; version.<\/p>\n<p>The practical consequence of no DAC: plasma half-life remains in the minutes-to-hours range (~30 minutes) rather than days. Research protocols therefore use multiple daily injections (typically 2\u20133x) to maintain GHRH signal rather than the weekly dosing of the DAC version. This mimics the short, pulsatile profile of endogenous GHRH and is the preferred research tool when pulse-timing matters \u2014 particularly in protocols studying physiological GH pulsatility alongside ghrelin-receptor agonists such as <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin\/\">ipamorelin<\/a>.<\/p>\n<p>Molecular weight approximately 3,367\u00a0Da. Supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. CJC-1295 without DAC is <strong>endast f\u00f6r laboratorieforsknings\u00e4ndam\u00e5l<\/strong> and is not intended for human or veterinary diagnosis or therapy. For mechanism, research context, and stacking protocols, see our <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin &amp; CJC-1295 research guide<\/a>.<\/p>\n<h2>Mechanism of Action \u2014 Pulsatile GHRH Signaling<\/h2>\n<p>Mod GRF 1-29 acts through the same pituitary GHRH receptor pathway as native GHRH, but with a kinetic profile that distinguishes it from both native GHRH and the DAC version:<\/p>\n<ul>\n<li><strong>GHRH receptor agonism<\/strong> \u2014 CJC-1295 without DAC binds GHRH receptors on pituitary somatotropes, stimulating growth-hormone synthesis and release. The amino-acid substitutions resist DPP-IV degradation, giving longer activity than native GHRH (which lasts only a few minutes) but still within the short-half-life range of 30 minutes.<\/li>\n<li><strong>Short, pulsatile kinetics<\/strong> \u2014 because there is no albumin tether, plasma levels rise and fall on a timescale matching the body&#8217;s natural GH pulse architecture. This is the critical mechanistic distinction from the DAC version, which produces a sustained non-pulsatile elevation.<\/li>\n<li><strong>GHRP synergy via parallel receptor<\/strong> \u2014 co-administration with a growth-hormone-releasing peptide such as <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin\/\">ipamorelin<\/a> (acting on the parallel ghrelin-receptor pathway) produces GH pulses substantially larger than either compound alone. The short-half-life version is often preferred for this stacking research because both peptides can be timed together for same-pulse amplification.<\/li>\n<\/ul>\n<p>The research implication: Mod GRF 1-29 is the tool of choice when the research question involves <em>physiological pulsatile GH signaling<\/em>. The DAC version is preferred when the question involves <em>sustained GH\/IGF-1 elevation<\/em>. Same peptide family; fundamentally different pharmacokinetics.<\/p>\n<h2>Publicerade forskningsapplikationer<\/h2>\n<p>CJC-1295 without DAC is used in laboratory research contexts that investigate:<\/p>\n<ul>\n<li><strong>Pulsatile GH release<\/strong> \u2014 physiological GH-pulse research matching native GHRH kinetics<\/li>\n<li><strong>Ipamorelin stacking<\/strong> \u2014 the canonical GHRH + GHRP research combination, often using the short-half-life variant for same-pulse timing<\/li>\n<li><strong>Body composition research<\/strong> \u2014 lean-mass, IGF-1 response, and body-composition research in pulsatile GH-axis modulation studies<\/li>\n<li><strong>Sleep architecture<\/strong> \u2014 pre-sleep dosing aligned with endogenous nocturnal GH-surge research<\/li>\n<li><strong>Recovery research<\/strong> \u2014 skeletal-muscle recovery protocols combined with <a href=\"https:\/\/medsbase.com\/sv\/bpc-157\/\">BPC-157<\/a> och <a href=\"https:\/\/medsbase.com\/sv\/tb-500\/\">TB-500<\/a> for connective-tissue and muscle research<\/li>\n<li><strong>Comparative kinetic research<\/strong> \u2014 side-by-side with <a href=\"https:\/\/medsbase.com\/sv\/cjc-1295-with-dac\/\">CJC-1295 med DAC<\/a> to isolate the albumin-tether effect on GH-axis signaling<\/li>\n<li><strong>GHRH analog comparisons<\/strong> \u2014 alongside <a href=\"https:\/\/medsbase.com\/sv\/sermorelin-peptide-guide\/\">sermorelin<\/a> och <a href=\"https:\/\/medsbase.com\/sv\/tesamorelin-peptide-guide\/\">tesamorelin<\/a> for cross-analog pharmacology research<\/li>\n<\/ul>\n<p>For broader context on GH-axis peptides see the <a href=\"https:\/\/medsbase.com\/sv\/peptides\/\">forskningspeptidkatalogen<\/a>.<\/p>\n<h2>Tillg\u00e4ngliga styrkor och koncentrationer<\/h2>\n<p>MedsBase stocks CJC-1295 without DAC in the following lyophilized vial sizes:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Flaskstyrka<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typisk anv\u00e4ndning<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">F\u00f6rpackningsstorlekar<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot dosing, titration, or short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 eller 20 flaskor<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard research strength \u2014 supports ~50 administrations at 100 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 eller 20 flaskor<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended protocols, multi-daily dosing, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 eller 20 flaskor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because Mod GRF 1-29 is typically dosed 2\u20133x daily at 100\u2013200\u00a0mcg per administration, a 5\u00a0mg vial supports 2\u20133 weeks of research use. All strengths are supplied as lyophilized powder at 99%+ HPLC purity.<\/p>\n<h2>How It Compares \u2014 CJC-1295 without DAC vs With DAC vs Ipamorelin<\/h2>\n<p>The three GH-axis peptides differ significantly in receptor, half-life, and stacking characteristics:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 utan DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">CJC-1295 med DAC<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ipamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Klass<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRH analog (short half-life)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRH analog (extended half-life)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GHRP (ghrelin-receptor)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Halveringstid<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~30 minutes<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~7 days (albumin-bound)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 hours<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>GH profile<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulsatile, physiological<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sustained elevation<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulsatile burst<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013200 mcg, 2\u20133x daily<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u20132 mg weekly<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u2013300 mcg, 2\u20133x daily<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Ideal research use<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pulse-timing research, same-pulse stacking<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sustained IGF-1 research<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Canonical pairing with CJC-1295<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Full protocol comparison in our <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin + CJC-1295 research guide<\/a>.<\/p>\n<h2>F\u00f6rvaring och rekonstitution<\/h2>\n<p><strong>F\u00f6rberedelse f\u00f6re rekonstitution:<\/strong> store lyophilized vials refrigerated at 2\u20138\u00a0\u00b0C in original packaging, stable up to 36 months. Avoid freeze-thaw cycles on the powder.<\/p>\n<p><strong>Rekonstitutionsprocedur:<\/strong> inject bacteriostatic water down the side wall of the peptide vial per the chart above. Swirl gently \u2014 do <strong>inte<\/strong> shake \u2014 and allow 5\u201310 minutes for full dissolution. Solution should be clear and colourless.<\/p>\n<p><strong>f\u00f6rvara l\u00f6sningen i kylsk\u00e5p vid 2\u20138 \u00b0C och anv\u00e4nd inom 30 dagar f\u00f6r optimal stabilitet. Frys inte den rekonstituerade l\u00f6sningen \u2014 frys-tina-cykler f\u00f6rs\u00e4mrar peptidens integritet. Kasta eventuella flaskor som visar oklarhet, f\u00e4llning eller f\u00e4rgf\u00f6r\u00e4ndring.<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days. Do not freeze reconstituted solution.<\/p>\n<h2 id=\"faqs\">Vanliga fr\u00e5gor<\/h2>\n<h3>What is CJC-1295 without DAC used for in research?<\/h3>\n<p>CJC-1295 without DAC (Mod GRF 1-29) is used in laboratory research investigating pulsatile growth-hormone release, GHRH-receptor pharmacology, IGF-1 response kinetics, sleep architecture, body composition, and synergistic stacking with GHRP peptides such as ipamorelin. It is <strong>inte<\/strong> FDA-approved and is sold here strictly for laboratory research use only.<\/p>\n<h3>What is the difference between CJC-1295 with and without DAC?<\/h3>\n<p>Both versions share the same core modified GHRH (1-29) sequence. The &#8220;with DAC&#8221; version has a maleimide group that binds covalently to serum albumin, extending plasma half-life from ~30 minutes to ~7 days. The &#8220;without DAC&#8221; version lacks this tether and retains the short half-life needed for pulsatile-research protocols. Choice depends on whether the research question requires sustained or pulsatile GHRH signaling.<\/p>\n<h3>What is the typical research dose?<\/h3>\n<p>Published preclinical protocols typically use 100\u2013200\u00a0mcg per administration, 2\u20133 times daily. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 4 ticks on a U-100 syringe delivers 100\u00a0mcg.<\/p>\n<h3>Is CJC-1295 without DAC FDA approved?<\/h3>\n<p>No. Neither the with-DAC nor without-DAC version of CJC-1295 has received FDA, EMA, or any regulatory approval. Original development by ConjuChem was discontinued. All CJC-1295 sold by research-use-only suppliers is for laboratory investigation only.<\/p>\n<h3>Why would I choose &#8220;without DAC&#8221; over &#8220;with DAC&#8221; in research?<\/h3>\n<p>&#8220;Without DAC&#8221; is preferred when the research question involves pulsatile physiological GH signaling, same-pulse ipamorelin stacking (both peptides timed together), or sleep-architecture research where pre-sleep dosing needs to align with the natural nocturnal GH surge. &#8220;With DAC&#8221; is preferred for sustained-IGF-1 elevation research and simpler weekly dosing.<\/p>\n<h3>How should CJC-1295 without DAC be stored?<\/h3>\n<p>Lyophilized vials: refrigerated at 2\u20138\u00a0\u00b0C in original packaging, stable up to 36 months. Reconstituted solution: refrigerated at 2\u20138\u00a0\u00b0C, use within 30 days. Do not freeze reconstituted solution.<\/p>\n<h3>How do I reconstitute CJC-1295 without DAC?<\/h3>\n<p>Follow the reconstitution chart above. Add bacteriostatic water down the side wall of the vial, swirl gently, and allow 5\u201310 minutes for full dissolution. Do <strong>inte<\/strong> inte.<\/p>\n<h3>Should I stack CJC-1295 without DAC with ipamorelin?<\/h3>\n<p>Yes \u2014 this is the canonical GH-axis research stack for pulsatile-signaling research. Both peptides are typically dosed together 2\u20133x daily; the short half-lives of both align so that each administration produces a same-pulse synergistic GH release. See our <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin-cjc-1295-stack-guide\/\">stack research guide<\/a>.<\/p>\n<h3>MedsBase f\u00f6rser retatrutide i lyofiliserade flaskor med 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg och 60 mg. Varje styrka finns i f\u00f6rpackningar med 10 eller 20 flaskor. Alla flaskor levereras med en renhet p\u00e5 99 %+ enligt HPLC och en analyscertifikat p\u00e5 beg\u00e4ran.<\/h3>\n<p>MedsBase carries CJC-1295 without DAC in 2\u00a0mg, 5\u00a0mg, and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial or 20-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request.<\/p>\n<h3>Does CJC-1295 without DAC cause side effects in research?<\/h3>\n<p>Published preclinical research has reported a reasonable safety profile at typical research doses. The most commonly reported observation is transient injection-site redness. Long-term human safety data are not available. Because the pulsatile kinetics are closer to native GHRH than the DAC version, some researchers consider this form more physiologically consistent.<\/p>\n<h3>What is the half-life of CJC-1295 Without DAC?<\/h3>\n<p>CJC-1295 without DAC (Modified GRF(1-29)) has a plasma half-life of approximately 30 minutes \u2014 extended from native GHRH(1-29)&#8217;s ~7 minutes by four amino acid substitutions that protect against enzymatic degradation. This moderate half-life produces a pulsatile GH release pattern, making it more physiologically similar to endogenous GHRH signalling than the longer-acting DAC form.<\/p>\n<h3>Why choose CJC-1295 Without DAC over the DAC version?<\/h3>\n<p>CJC-1295 without DAC preserves a pulsatile GH secretion pattern similar to endogenous GHRH physiology. Research protocols prioritising physiological pulsatility \u2014 particularly when stacking with a GHRP like Ipamorelin \u2014 typically use the no-DAC form. The DAC version is favoured in research requiring maximal GH area-under-the-curve with less frequent administration.<\/p>\n<h3>Can I order CJC-1295 without DAC for international shipping?<\/h3>\n<p>Yes. MedsBase ships CJC-1295 without DAC worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. Orders ship in temperature-controlled packaging with full tracking.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Andra peptider f\u00f6r forskning om \u00e5terh\u00e4mtning och prestanda<\/h2>\n<ul>\n<li><a href=\"\/sv\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 forskning om \u00e5terh\u00e4mtning av senor, ligament och tarm<\/li>\n<li><a href=\"\/sv\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 forskning om \u00e5terh\u00e4mtning av mjukv\u00e4vnad och blodk\u00e4rl<\/li>\n<li><a href=\"\/sv\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektiv ghrelinagonist \u2014 ren GH-puls utan kortisol\/prolaktin<\/li>\n<li><a href=\"\/sv\/cjc-1295-with-dac\/\"><strong>CJC-1295 med DAC<\/strong><\/a> \u2014 GHRH-analog med f\u00f6rl\u00e4ngd halveringstid<\/li>\n<li><a href=\"\/sv\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Kopparpeptid \u2014 forskning om hud- och bindv\u00e4vsregeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Vidarel\u00e4sning<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 L\u00e4r dig forskningen bakom denna peptid<\/strong><\/p>\n<p style=\"margin: 0;\">L\u00e4s v\u00e5r kompletta evidensbaserade guide: <a href=\"https:\/\/medsbase.com\/sv\/ipamorelin-cjc-1295-stack-guide\/\"><strong>Ipamorelin &amp; CJC-1295 \u2014 mechanism, stacking &amp; protocols<\/strong><\/a>. Covers pulsatile vs sustained GHRH pharmacology, DAC vs no-DAC kinetic differences, canonical stacking protocols, reconstitution, and safety notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Supports growth signaling<br \/>\n\u2705 Enhances metabolic regulation<br \/>\n\u2705 Promotes tissue regeneration<br \/>\n\u2705 Improves recovery pathways<br \/>\n\u2705 Boosts hormonal balance<\/p>\n<p><strong>CJC-1295 med DAC<\/strong> inneh\u00e5ller syntetiska peptidf\u00f6reningar.<\/p>","protected":false},"featured_media":70945,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5471],"class_list":{"0":"post-69005","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptides","7":"product_tag-cjc-1295-without-dac","9":"first","10":"instock","11":"shipping-taxable","12":"purchasable","13":"product-type-variable","14":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/69005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=69005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/70945"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=69005"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=69005"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=69005"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=69005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}